Cited by 504IL-33, ST2, and ILC PathwaysLiver physiology and pathologyLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.

Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis

Open access

Mchedlidze, Tamar, Waldner, Maximilian, Zopf, Steffen, Walker, Jennifer, Rankin, Andrew L., Schuchmann, Marcus, Voehringer, David, McKenzie, Andrew N.J., Neurath, Markus F., Pflanz, Stefan, Wirtz, Stefan·2013·Immunity

DOI 10.1016/j.immuni.2013.07.018PMC PMC4172965

Open this paper in CoChat — free account Open PDF

Abstract

Liver fibrosis is a consequence of chronic liver diseases and thus a major cause of mortality and morbidity. Clinical evidence and animal studies suggest that local tissue homeostasis is disturbed due to immunological responses to chronic hepatocellular stress. Poorly defined stress-associated inflammatory networks are thought to mediate gradual accumulation of extracellular-matrix components, ultimately leading to fibrosis and liver failure. Here we have reported that hepatic expression of interleukin-33 (IL-33) was both required and sufficient for severe hepatic fibrosis in vivo. We have demonstrated that IL-33's profibrotic effects related to activation and expansion of liver resident innate lymphoid cells (ILC2). We identified ILC2-derived IL-13, acting through type-II IL-4 receptor-dependent signaling via the transcription factor STAT6 and hepatic stellate-cell activation, as a critical downstream cytokine of IL-33-dependent pathologic tissue remodeling and fibrosis. Our data reveal key immunological networks implicated in hepatic fibrosis and support the concept of modulation of IL-33 bioactivity for therapeutic purposes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2013.07.018

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Liver fibrosis
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
Schmitz, J., Owyang, A. M., Oldham, E. R., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,773
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M. G., Langford, T. K. A., Bucks, C. M., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 2,079
Self-citation
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2009) · Nature · doi:10.1038/nature08636 · Cited by 1,994
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,728
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli, L. A., Sonnenberg, G. F., Abt, M. C., Alenghat, T., Ziegler, C. G. K., Doering, T. A., Angelosanto, J., Laidlaw, B. J., Yang, C. Y., Sathaliyawala, T., et al. (2011) · Nature Immunology · doi:10.1038/ni.2131 · Cited by 1,327
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
Mjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166
Systemically dispersed innate IL-13–expressing cells in type 2 immunity
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & Locksley, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003988107 · Cited by 1,134

Flagged first, then by citations

Show all 54 references

2 of the 54 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 504

Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine
Fournié, J., & Poupot, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02506 · Cited by 99
Group‐2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2‐Neutrophil‐Induced Immunosuppression
Xu, X., Ye, L., Zhang, Q., Shen, H., Li, S., Zhang, X., Ye, M., & Liang, T. (2021) · Hepatology · doi:10.1002/hep.31855 · Cited by 98
Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
Yan, Y., Zeng, J., Xing, L., & Li, C. (2021) · Biomedicines · doi:10.3390/biomedicines9081014 · Cited by 103
Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn’s Disease
Günther, C., Ruder, B., Stolzer, I., Dorner, H., He, G.-W., Chiriac, M. T., Aden, K., Strigli, A., Bittel, M., Zeißig, S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.031 · Cited by 99
Self-citation
Transient receptor potential melastatin 8 ion channel in macrophages modulates colitis through a balance-shift in TNF-alpha and interleukin-10 production
Khalil, M., Babeș, A., Lakra, R., Foersch, S., Reeh, P. W., Wirtz, S. J., Becker, C., Neurath, M. F., & Engel, M. A. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.16 · Cited by 93
Self-citation
Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs
Nussbaum, K., Burkhard, S., Ohs, I., Mair, F., Klose, C. S. N., Arnold, S. J., Diefenbach, A., Tugues, S., & Becher, B. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20162031 · Cited by 98
Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis
Imai, J., Kitamoto, S., Sugihara, K., Nagao-Kitamoto, H., Hayashi, A., Morhardt, T. L., Kuffa, P., Higgins, P. D. R., Barnich, N., & Kamada, N. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0138-4 · Cited by 91
The cytokines of pulmonary fibrosis: Much learned, much more to learn
Luzina, I. G., Todd, N. W., Sundararajan, S., & Atamas, S. P. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.008 · Cited by 93
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
Chen, Y., & Tian, Z. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00561-z · Cited by 92
Hyaluronan’s Role in Fibrosis: A Pathogenic Factor or a Passive Player?
Albeiroti, S., Soroosh, A., & de la Motte, C. A. (2015) · BioMed Research International · doi:10.1155/2015/790203 · Cited by 94
STAT3 Activation in Th17 and Th22 Cells Controls IL-22–Mediated Epithelial Host Defense during Infectious Colitis
Backert, I., Koralov, S. B., Wirtz, S. J., Kitowski, V., Billmeier, U., Martini, E., Hofmann, K., Hildner, K., Wittkopf, N., Brecht, K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303076 · Cited by 89
Self-citation
Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis
Jeftic, I. D., Jovicic, N. U., Pantic, J. M., Arsenijević, N., Lukić, M. L., & Pejnovic, N. N. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00178 · Cited by 89
New dog and new tricks: evolving roles for IL-33 in type 2 immunity
Lott, J. M., Sumpter, T. L., & Turnquist, H. R. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri1214-595r · Cited by 90
Perilipin‐2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra‐hepatocyte actions
Orlicky, D. J., Libby, A. E., Bales, E. S., McMahan, R. H., Monks, J., Rosa, F. G. L., & McManaman, J. L. (2018) · The Journal of Physiology · doi:10.1113/jp277140 · Cited by 88
The Roles of Liver-Resident Lymphocytes in Liver Diseases
Wang, Y., & Zhang, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01582 · Cited by 93
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
Ercolano, G., Gomez‐Cadena, A., Dumauthioz, N., Vanoni, G., Kreutzfeldt, M., Wyss, T., Michalik, L., Loyon, R., Ianaro, A., Ho, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22764-2 · Cited by 87
Group 2 Innate Lymphoid Cells in Health and DiseasePreprint
Kim, B., & Artis, D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016337 · Cited by 86
The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
Wasmer, M.-H., & Krebs, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00682 · Cited by 84
Common-Lymphoid-Progenitor-Independent Pathways of Innate and T Lymphocyte Development
Ghaedi, M., Steer, C. A., Martínez-González, I., Halim, T. Y. F., Abraham, N. B., & Takei, F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.039 · Cited by 84
Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis
Baghaei, K., Mazhari, S., Tokhanbigli, S., Parsamanesh, G., Alavifard, H., Schaafsma, D., & Ghavami, S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.12.012 · Cited by 83
Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis
Distler, J. H. W., Feghali‐Bostwick, C. A., Soare, A., Asano, Y., Distler, O., & Abraham, D. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39865 · Cited by 86
Group 2 innate lymphoid cells in disease
Halim, T. Y. F. (2015) · International Immunology · doi:10.1093/intimm/dxv050 · Cited by 81
Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression
Zhang, Q., Lou, Y., Bai, X., & Liang, T. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i31.3500 · Cited by 81
Group 2 Innate Lymphoid Cells Attenuate Inflammatory Arthritis and Protect from Bone Destruction in Mice
Omata, Y., Frech, M., Primbs, T., Lucas, S., Andreev, D., Scholtysek, C., Sarter, K., Kindermann, M., Yeremenko, N. G., Baeten, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.005 · Cited by 80
Self-citation
Hepatic recruitment of eosinophils and their protective function during acute liver injury
Xu, L., Yang, Y., Wen, Y., Jeong, J., Emontzpohl, C., Atkins, C. L., Sun, Z., Poulsen, K. L., Hall, D. R., Bynon, J. S., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.02.024 · Cited by 80
Composition and functionality of the intrahepatic innate lymphoid cell‐compartment in human nonfibrotic and fibrotic livers
Forkel, M., Berglin, L., Kekäläinen, E., Carlsson, A., Svedin, E., Michaëlsson, J., Nagasawa, M., Erjefalt, J. S., Mori, M., Flodström‐Tullberg, M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646890 · Cited by 83
Deciphering the Roles of Innate Lymphoid Cells in Cancer
Bruchard, M., & Ghiringhelli, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00656 · Cited by 79
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Wiering, L., Subramanian, P., & Hammerich, L. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.010 · Cited by 80
IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
Gao, Y., Liu, Y., Yang, M., Guo, X., Zhang, M., Li, H., Li, J., & Zhao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9259 · Cited by 79
Eosinophil depletion suppresses radiation-induced small intestinal fibrosis
Takemura, N., Kurashima, Y., Mori, Y., Okada, K., Ogino, T., Osawa, H., Matsuno, H., Lamichhane, A., Kaneto, S., Park, E. J., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0333 · Cited by 79
Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
Garbuzenko, D. V. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i12.3662 · Cited by 87
IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis
Salvo, C. D., Wang, X.-M., Pastorelli, L., Mattioli, B., Omenetti, S., Buela, K.-A. G., Chowdhry, S., Garg, R. R., Goodman, W. A., Rodriguez‐Palacios, A., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.028 · Cited by 77
Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-α and IL-33 Produced by Plasmacytoid Dendritic Cells
Watanabe, T., Yamashita, K., Arai, Y., Minaga, K., Kamata, K., Nagai, T., Komeda, Y., Takenaka, M., Hagiwara, S., Ida, H., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700060 · Cited by 77
Antifibrotic Therapies in the Liver
Schuppan, D., & Mehal, W. Z. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1550055 · Cited by 76
Glucocorticoids and Androgens Protect From Gastric Metaplasia by Suppressing Group 2 Innate Lymphoid Cell Activation
Busada, J. T., Peterson, K. N., Khadka, S., Xu, X., Oakley, R. H., Cook, D. N., & Cidlowski, J. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.075 · Cited by 75
Type 2 Innate Lymphoid Cells Impede IL-33–Mediated Tumor Suppression
Long, A., Dominguez, D., Qin, L., Chen, S., Fan, J., Zhang, M., Fang, D., Zhang, Y., Kuzel, T. M., & Zhang, B. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800173 · Cited by 74
Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohnʼs Ileitis
Masterson, J. C., Capocelli, K. E., Hosford, L., Biette, K. A., McNamee, E. N., de Zoeten, E. F., Harris, R. F., Fernando, S. D., Jedlicka, P., Protheroe, C. A., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000512 · Cited by 73
Alarmins in Frozen Shoulder: A Molecular Association Between Inflammation and Pain
Cher, J., Akbar, M., Kitson, S. M., Crowe, L. A. N., Melchor, E. G., Hannah, S. C., McLean, M., Fazzi, U. G., Kerr, S. C., Murrell, G. A. C., et al. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517741127 · Cited by 72
Reciprocal regulation of IL-33 receptor–mediated inflammatory response and pulmonary fibrosis by TRAF6 and USP38
Yi, X.-M., Li, M., Chen, Y.-D., Shu, H., & Li, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116279119 · Cited by 71
Very-low-density lipoprotein receptor-enhanced lipid metabolism in pancreatic stellate cells promotes pancreatic fibrosis
Yang, X., Chen, J., Wang, J., Ma, S., Feng, W., Wu, Z., Guo, Y., Zhou, H., Mi, W., Chen, W., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.001 · Cited by 70
Type 3 ILCs in Lung Disease
Ardain, A., Porterfield, J. Z., Kløverpris, H. N., & Leslie, A. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00092 · Cited by 73
Innate lymphoid cells in inflammatory bowel diseases
Peters, C. P., Mjösberg, J., Bernink, J. H., & Spits, H. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.10.004 · Cited by 69
The role of IL-33/ST2L signals in the immune cells
Lü, J., Kang, J., Zhang, C., & Zhang, X. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.01.008 · Cited by 69
Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis
Hams, E., Bermingham, R., & Fallon, P. G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00597 · Cited by 70
A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2–mediated inflammation
Knipfer, L., Schulz-Kuhnt, A., Kindermann, M., Greif, V., Symowski, C., Voehringer, D., Neurath, M. F., Atreya, I., & Wirtz, S. J. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182111 · Cited by 68
Self-citation
Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis
Watanabe, T., Sadakane, Y., Yagama, N., Sakurai, T., Ezoe, H., Kudo, M., Chiba, T., & Strober, W. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.144 · Cited by 68
Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences
Sundnes, O., Pietka, W., Loos, T., Sponheim, J., Rankin, A. L., Pflanz, S., Bertelsen, V., Sitek, J. C., Fosse, J. H., Haraldsen, G., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.85 · Cited by 67
Self-citation
Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn’s disease-associated fibrosis
Sadler, T. M., Bhasin, J., Xu, Y., Barnholz-Sloan, J., Chen, Y., Ting, A. H., & Stylianou, E. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0193-6 · Cited by 75
IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cells
Mchedlidze, T., Kindermann, M., Neves, A. T., Voehringer, D., Neurath, M. F., & Wirtz, S. J. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.20 · Cited by 67
Self-citation
Quantitative phosphoproteomic analysis of IL‐33‐mediated signaling
Pinto, S. M., Nirujogi, R. S., Rojas, P. L., Patil, A. H., Manda, S. S., Subbannayya, Y., Roa, J. C., Chatterjee, A., Prasad, T. S. K., & Pandey, A. (2014) · PROTEOMICS · doi:10.1002/pmic.201400303 · Cited by 69
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
Pejnovic, N. N., Jeftic, I. D., Jovicic, N. U., Arsenijević, N., & Lukić, M. L. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i44.9706 · Cited by 64
Foxp3+ Regulatory T Cells Inhibit CCl4-Induced Liver Inflammation and Fibrosis by Regulating Tissue Cellular Immunity
Ikeno, Y., Ohara, D., Takeuchi, Y., Watanabe, H., Kondoh, G., Taura, K., Uemoto, S., & Hirota, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584048 · Cited by 62
Macrophage Activation and Functions during Helminth Infection: Recent Advances from the Laboratory Mouse
Rolot, M., & Dewals, B. G. (2018) · Journal of Immunology Research · doi:10.1155/2018/2790627 · Cited by 64
NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation
Neumann, K., Schiller, B., & Tiegs, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092732 · Cited by 64
Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy
(2024) · doi:10.1146/annurev-pharmtox-020524-012013 · Cited by 64
Interleukin‐1 Family Cytokines in Liver Diseases
Tsutsui, H., Cai, X., & Hayashi, S. (2015) · Mediators of Inflammation · doi:10.1155/2015/630265 · Cited by 63
IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential
Sheng, F., Mi, L., Yu, J.-M., Yang, S., Zou, L., Yang, G., & Zhang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1533335 · Cited by 71
Amphiregulin couples IL1RL1 + regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity
Sun, R., Zhao, H., Gao, D. S., Ni, A., Li, H., Chen, L., Lu, X., Chen, K., & Lu, B. (2023) · Science Advances · doi:10.1126/sciadv.add7399 · Cited by 62
Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth
Donahue, K. L., Watkoske, H. R., Kadiyala, P., Du, W., Brown, K. L., Scales, M. K., Elhossiny, A. M., Espinoza, C. E., Opsahl, E. L. L., Griffith, B. D., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0100 · Cited by 60
Innate lymphoid cells in defense, immunopathology and immunotherapy
Cording, S., Medvedovic, J., Aychek, T., & Eberl, G. (2016) · Nature Immunology · doi:10.1038/ni.3448 · Cited by 59
Type 3 innate lymphoid cell: a new player in liver fibrosis progression
Wang, S., Li, J., Wu, S., Cheng, L.-S., Shen, Y. L., Ma, W., She, W., Yang, C., Wang, J., & Jiang, W. (2018) · Clinical Science · doi:10.1042/cs20180482 · Cited by 59
Mast Cells in Liver Fibrogenesis
Weiskirchen, R., Meurer, S. K., Liedtke, C., & Huber, M. (2019) · Cells · doi:10.3390/cells8111429 · Cited by 60
Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cells
Yang, L.-X., Qi, C., Lu, S., Ye, X.-S., Merikhian, P., Zhang, D.-Y., Yao, T., Zhao, J.-S., Wu, Y., Jia, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55738-1 · Cited by 57
Upregulation of Interleukin-33 in obstructive renal injury
Chen, W., Chang, Y., Su, C., Tsai, T., Chen, S., Hsing, C., & Yang, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.010 · Cited by 57
The balance of power: innate lymphoid cells in tissue inflammation and repair
Castellanos, J. G., & Longman, R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124617 · Cited by 57
NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells
Bi, J., Cui, L., Yu, G., Yang, X., Chen, Y., & Wan, X. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601830 · Cited by 56
Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score
Jeffery, H. C., McDowell, P., Lutz, P. L., Wawman, R. E., Roberts, S., Bagnall, C., Birtwistle, J., Adams, D., & Oo, Y. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188649 · Cited by 57
Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation
Wallrapp, A., Riesenfeld, S. J., Burkett, P. R., & Kuchroo, V. K. (2018) · Immunological Reviews · doi:10.1111/imr.12702 · Cited by 57
Innate lymphoid cells: New paradigm in immunology of inflammation
Kumar, V. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.11.003 · Cited by 56
Modulation of Liver Inflammation and Fibrosis by Interleukin-37
Mountford, S., Effenberger, M., Noll‐Puchta, H., Griessmair, L., Ringleb, A., Haas, S., Denk, G., Reiter, F. P., Mayr, D. C., Dinarello, C. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.603649 · Cited by 57
A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis
Neumann, K., Karimi, K., Meiners, J., Voetlause, R., Steinmann, S., Dammermann, W., Lüth, S., Asghari, F., Wegscheid, C., Horst, A. K., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600418 · Cited by 53
Single‐cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma
He, Y., Luo, J., Zhang, G., Jin, Y., Wang, N., Lu, J., Li, C., Guo, X., Qin, N., Dai, J., et al. (2022) · Hepatology · doi:10.1002/hep.32444 · Cited by 49
Single‐cell RNA sequencing reveals the heterogeneity and intercellular communication of hepatic stellate cells and macrophages during liver fibrosis
Cheng, S. G., Zou, Y., Zhang, M., Bai, S., Tao, K., Wu, J., Shi, Y., Wu, Y., Lu, Y., He, K., et al. (2023) · MedComm · doi:10.1002/mco2.378 · Cited by 60
Innate lymphoid cells in tissue homeostasis and diseases
Ignácio, A., Breda, C. N. D. S., & Câmara, N. O. S. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i23.979 · Cited by 54
The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis
Shen, X., Peng, Y., & Li, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01450 · Cited by 51
Materials and extracellular matrix rigidity highlighted in tissue damages and diseases: Implication for biomaterials design and therapeutic targets
Park, J. H., Jo, S. B., Lee, J., Lee, H., Knowles, J. C., & Kim, H. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.06.003 · Cited by 49
Inflammation and cancer: molecular mechanisms and clinical consequences
Akkız, H., Şimşek, H., Balcı, D., Ülger, Y., Onan, E., Ozturk, N. A., & Delik, A. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1564572 · Cited by 59
The potential role of IL-33/ST2 signaling in fibrotic diseases
Gao, Q., Li, Y., & Li, M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0115-012r · Cited by 50
Dichotomous function of IL-33 in health and disease: From biology to clinical implications
Braun, H., Afonina, I. S., Mueller, C., & Beyaert, R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.010 · Cited by 50
Expansion of CD25 + Innate Lymphoid Cells Reduces Atherosclerosis
Engelbertsen, D., Foks, A. C., Alberts‐Grill, N., Kuperwaser, F., Chen, T., Lederer, J. A., Jarolı́m, P., Grabie, N., & Lichtman, A. H. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306048 · Cited by 49
In mouse chronic pancreatitis CD25+FOXP3+ regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response
Glaubitz, J., Wilden, A., Golchert, J., Homuth, G., Völker, U., Bröker, B. M., Thiele, T., Lerch, M. M., Mayerle, J. V., Aghdassi, A. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32195-2 · Cited by 52
Non-cytotoxic Cardiac Innate Lymphoid Cells Are a Resident and Quiescent Type 2-Commited Population
Bracamonte‐Baran, W., Chen, G., Hou, X., Talor, M. V., Choi, H. S., Davogustto, G., Taegtmeyer, H., Sung, J., Hackam, D. J., Nauen, D. W., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00634 · Cited by 49
Lipid mediators as regulators of human ILC2 function in allergic diseases
Kónya, V., & Mjösberg, J. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.07.006 · Cited by 49
Friend or Foe? The Ambiguous Role of Innate Lymphoid Cells in Cancer Development
Mattner, J., & Wirtz, S. J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.10.004 · Cited by 47
Self-citation
HMGB1 amplifies ILC2-induced type-2 inflammation and airway smooth muscle remodelling
Loh, Z., Simpson, J., Ullah, M. A., Zhang, V., Gan, W. J., Lynch, J. P., Werder, R. B., Sikder, M. A. A., Lane, K., Sim, C. B., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008651 · Cited by 45
IL-33 Contributes to Schistosoma japonicum-induced Hepatic Pathology through Induction of M2 Macrophages
Peng, H., Zhang, Q., Li, X., Liu, Z., Shen, J., Sun, R., Wei, J., Zhao, J., Wu, X., Feng, F., et al. (2016) · Scientific Reports · doi:10.1038/srep29844 · Cited by 46
Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells
Weiskirchen, R., & Tacke, F. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.62 · Cited by 46
IL-33-ST2 Axis in Liver Disease: Progression and Challenge
Sun, Z., Chang, B., Gao, M., Zhang, J., & Zou, Z. (2017) · Mediators of Inflammation · doi:10.1155/2017/5314213 · Cited by 47
The roles of interleukin‐1 receptor accessory protein in certain inflammatory conditions
Mehrabadi, A. Z., Aghamohamadi, N., Khoshmirsafa, M., Aghamajidi, A., Pilehforoshha, M., Massoumi, R., & Falak, R. (2022) · Immunology · doi:10.1111/imm.13462 · Cited by 45
IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection
Xu, L., Wei, C., Chen, Y., Wu, Y., Shou, X., Chen, W., Lu, D., Sun, H., Li, W., Yu, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34660-4 · Cited by 46
Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B
Yang, Z., Tang, T., Wei, X., Yang, S. C., & Tian, Z. (2015) · Innate Immunity · doi:10.1177/1753425915586074 · Cited by 45
Wounds that heal and wounds that don’t − The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
Millar, N. L., O’Donnell, C., McInnes, I. B., & Brint, E. K. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.007 · Cited by 45
Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection
Wang, S., Xia, P., Chen, Y., Huang, G., Xiong, Z., Liu, J., Li, C., Ye, B., Du, Y., & Fan, Z. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.019 · Cited by 46
Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33
He, X., Xie, J., Wang, Y., Fan, X., Su, Q., Sun, Y., Lei, N., Zhang, D., Gao, G., & Pan, W. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006957 · Cited by 44
An ST2‐dependent role of bone marrow‐derived group 2 innate lymphoid cells in pulmonary fibrosis
Zhao, Y., Santos, F. G. D. L., Wu, Z. B., Liu, T., & Phan, S. H. (2018) · The Journal of Pathology · doi:10.1002/path.5092 · Cited by 44
Group 2 Innate Lymphoid Cells in the Lung
Drake, L. Y., & Kita, H. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00001-7 · Cited by 43
Regulation of metabolic health and adipose tissue function by group 2 innate lymphoid cells
Cautivo, K. M., & Molofsky, A. B. (2016) · European Journal of Immunology · doi:10.1002/eji.201545562 · Cited by 43
Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells
von Seth, E., Zimmer, C. L., Hansson, M. R., Barakat, A., Arnelo, U., Bergquist, A. M., Ivarsson, M. A., & Björkström, N. K. (2018) · European Journal of Immunology · doi:10.1002/eji.201847608 · Cited by 45
Group 2 Innate Lymphoid Cells: Central Players in a Recurring Theme of Repair and Regeneration
Messing, M., Jan-Abu, S. C., & McNagny, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041350 · Cited by 44

Authors: Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., & Wirtz, S.
Affiliations: Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
MRC Laboratory of Molecular Biology (GB)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Johannes Gutenberg University Mainz (DE)
Corresponding author: Wirtz, Stefan
ORCID: Waldner, Maximilian
Walker, Jennifer
Voehringer, David
McKenzie, Andrew N.J.
Neurath, Markus F.
Wirtz, Stefan
Venue: Immunity
Publisher: Elsevier BV
Published: 2013-08
Volume: 39
Issue: 2
Pages: 357-371
ISSN: 1074-7613 (ISSN-L)
DOI: 10.1016/j.immuni.2013.07.018
PMC: PMC4172965
OpenAlex: W1997883939
Cited by: 502
References: 54
Citations by year: 2026: 13 · 2025: 33 · 2024: 30 · 2023: 33 · 2022: 35 · 2021: 37 · 2020: 46 · 2019: 43 · 2018: 48 · 2017: 50 · 2016: 47 · 2015: 47 · 2014: 35 · 2013: 4
FWCI: 24.68
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 386 d)
Locations: Immunity (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: IL-33, liver fibrosis, innate lymphoid cells, ILC2, IL-13, STAT6, hepatic stellate cells, extracellular matrix remodeling, liver inflammation, chronic liver disease
MeSH terms: Interleukin-33, Animals, Cells, Cultured, Inflammation, Interleukins, Liver, Liver Cirrhosis, Lymphocyte Activation, Lymphocytes, Mice, Inbred BALB C, Mice, Inbred C57BL, Signal Transduction, Mice, Knockout, Interleukin-13, Adoptive Transfer, Cell Proliferation, STAT6 Transcription Factor, Mice, Receptors, Interleukin-4, Type II, Hepatic Stellate Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks